{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:21:50Z","timestamp":1779117710980,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":471,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.coph.2012.02.007","type":"journal-article","created":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T22:34:33Z","timestamp":1332369273000},"page":"223-224","source":"Crossref","is-referenced-by-count":7,"title":["Is losartan the drug for all seasons?"],"prefix":"10.1016","volume":"12","author":[{"given":"Francesco","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B","family":"Rifkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2012.02.007_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/17425255.2011.570333","article-title":"Pharmacokinetic evaluation of losartan","volume":"7","author":"Burnier","year":"2011","journal-title":"Expert Opin Metab Toxicol"},{"key":"10.1016\/j.coph.2012.02.007_bib0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2012.02.007_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Maran syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.coph.2012.02.007_bib0020","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2012.02.007_bib0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blocade attenuates TGF-\u03b2-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2012.02.007_bib0030","doi-asserted-by":"crossref","first-page":"82ra37","DOI":"10.1126\/scitranslmed.3002227","article-title":"Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia","volume":"3","author":"Burks","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2012.02.007_bib0035","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1073\/pnas.0900351106","article-title":"AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist","volume":"106","author":"Rhodes","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2012.02.007_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coph.2010.11.003","article-title":"AT1 receptors as mechanosensors","volume":"11","author":"Mederos y Schnitzler","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2012.02.007_bib0045","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1093\/hmg\/ddq409","article-title":"Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome","volume":"19","author":"Nistala","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2012.02.007_bib0050","doi-asserted-by":"crossref","first-page":"e20856","DOI":"10.1371\/journal.pone.0020856","article-title":"Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice","volume":"6","author":"Bish","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212000306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212000306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T21:21:31Z","timestamp":1543094491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489212000306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1471489212000306"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2012.02.007","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}